Form4.ai tracks every SEC insider trade in real time. See every ETON insider filing with a free account — no card.
See every ETON insider filing — free account, no card.
Free accountEton Pharmaceuticals, Inc. (ETON) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $6.1M. Most recent filing: Oct. 6, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 6, 2026 SEC filing | Krempa David Chief Business Officer | Vest & sell-to-cover | +6,356 sh | — |
| Aug 31, 2026 SEC filing Amended: Corrected by the insider on Aug 31, 2026 · the original filing reported $3.1M | MAIER PAUL V Director | Vest & sell-to-cover | +12,500 sh | — |
| Aug 24, 2026 SEC filing | Krempa David Chief Business Officer | Cashless exercise | $1,444,000 | — |
Create a free account to see all 4 ETON filings from the last 90 days. No card needed.
Create free accountWant ETON insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.